1231 A phase I study of axitinib (AG-013736) combined with paclitaxel/carboplatin (P/C), gemcitabine/cisplatin (Gem/Cis) or pemetrexed/cisplatin (Pem/Cis) in patients (pts) with solid tumours, including advanced non-small cell lung cancer (NSCLC)
M.F. Kozloff; L.P. Martin; M. Krzakowski; T.A. Samuel; J. Tarazi; B. Rosbrook; M. Tortorici; A.J. Olszanski; R.B. Cohen
- 作者M.F. Kozloff; L.P. Martin; M. Krzakowski; T.A. Samuel; J. Tarazi; B. Rosbrook; M. Tortorici; A.J. Olszanski; R.B. Cohen
- 卷第7卷
- 期第2期
- 文件大小51.56KB
- 发表时间2009
- DOI10.1016/s1359-6349(09)70443-4